Skip to main content Back to Top
Advertisement

11/13/2019

Heparin Injection

Products Affected - Description

    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0540-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0540-11
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 2 mL single dose vial, 25 count, NDC 63323-0276-02
    • Heparin Sodium solution for injection, Fresenius Kabi, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 63323-0540-31
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 0.5 mL preservative-free vial, 25 count, NDC 63323-0543-02
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0542-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 63323-0459-09
    • Heparin Sodium solution for injection, Fresenius Kabi, 10,000 unit/mL, 5 mL multiple dose vial, 25 count, NDC 63323-0542-07
    • Heparin Sodium solution for injection, Fresenius Kabi, 20,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0915-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 63323-0262-01
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 1 mL prefilled syringe, 24 count, NDC 76045-0108-10
    • Heparin Sodium solution for injection, Fresenius Kabi, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 63323-0047-10
    • Heparin Sodium solution for injection, Hikma, 1,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0391-12
    • Heparin Sodium solution for injection, Hikma, 10,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0410-12
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00641-0400-12
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 1 mL single dose vial, 25 count, NDC 00409-2720-01
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00069-0058-01
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 30 mL multiple dose vial, 10 count, NDC 00069-0137-03
    • Heparin Sodium solution for injection, Pfizer, 10,000 unit/mL, 0.5 mL preservative-free Carpuject syringe, 50 count, NDC 00409-1316-32
    • Heparin Sodium solution for injection, Pfizer, 10,000 unit/mL, 1mL single dose vial, 25 count, NDC 00409-2721-01
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00069-0059-01
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00409-2723-02
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1mL Carpuject syringe, 50 count, NDC 00409-1402-12
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1mL single dose vial, 25 count, NDC 00409-2723-01
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0400-01
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 25021-0400-10
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 2 mL single dose vial, 25 count, NDC 25021-0401-02
    • Heparin Sodium solution for injection, Sagent, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 25021-0400-30
    • Heparin Sodium solution for injection, Sagent, 10,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0403-01
    • Heparin Sodium solution for injection, Sagent, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 25021-0403-04
    • Heparin Sodium solution for injection, Sagent, 20,000 unit/mL, 1mL multiple dose vial, 25 count, NDC 25021-0404-01
    • Heparin Sodium solution for injection, Sagent, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 25021-0402-10

Reason for the Shortage

    • Fresenius Kabi has put heparin on a protective allocation due to a potential shortage of raw ingredient. The letter describing this in detail is available at the following link: https://www.fresenius-kabi.com/us/news/fresenius-kabi-responds-to-a-potential-shortage-of-heparin.
    • Hikma did not provide a reason for the shortage.
    • Mylan has heparin injection available.
    • Pfizer has heparin on shortage due to manufacturing delays.
    • Sagent has heparin on shortage due to manufacturing issues and increased demand.

Available Products

    • Heparin Sodium solution for injection, BBraun, 10,000 unit/mL, 0.5 mL prefilled syringe, 10 count, NDC 00264-5705-10
    • Heparin Sodium solution for injection, Hikma, 5,000 unit/mL, 1 mL syringe, 10 count, NDC 00641-6199-12
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0402-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 10 mL vial, 25 count, NDC 71288-0402-11
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 10 mL vial, NDC 71288-0402-10
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 30 mL vial, 25 count, NDC 71288-0402-31
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 unit/mL, 30 mL vial, NDC 71288-0402-30
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 1,000 units/mL, 2 mL vial, 25 count, NDC 71288-0400-03
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0404-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 1 mL vial, NDC 71288-0404-01
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 4 mL vial, 25 count, NDC 71288-0404-05
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 10,000 unit/mL, 4 mL vial, NDC 71288-0404-04
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 1 mL vial, 25 count, NDC 71288-0403-02
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 10 mL vial, 25 count, NDC 71288-0403-11
    • Heparin Sodium solution for injection, Meitheal Pharmaceuticals, 5,000 unit/mL, 10 mL vial, NDC 71288-0403-10
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0372-99
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 67457-0385-99
    • Heparin Sodium solution for injection, Mylan, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 67457-0384-99
    • Heparin Sodium solution for injection, Mylan, 10,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0602-99
    • Heparin Sodium solution for injection, Mylan, 10,000 unit/mL, 4 mL multiple dose vial, 25 count, NDC 67457-0603-99
    • Heparin Sodium solution for injection, Mylan, 20,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0373-99
    • Heparin Sodium solution for injection, Mylan, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 67457-0374-99
    • Heparin Sodium solution for injection, Mylan, 5,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 67457-0383-99
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 10 mL multiple dose vial, 25 count, NDC 00409-2720-02
    • Heparin Sodium solution for injection, Pfizer, 1,000 unit/mL, 30 mL multiple dose vial, 25 count, NDC 00409-2720-03
    • Heparin Sodium solution for injection, Pfizer, 5,000 unit/mL, 1 mL multiple dose vial, 25 count, NDC 00069-0059-03
    • Heparin Sodium solution for injection, Sagent, 5,000 unit/mL, 1 mL vial, 25 count, NDC 25021-0402-01

Estimated Resupply Dates

    • Fresenius Kabi has short-dated heparin 5,000 unit/mL 1 mL prefilled syringes available with an expiration date of <7 months. The 10,000 unit/mL 4 mL vials are on back order and the company cannot estimate a release date. All other presentations are on allocation.
    • Hikma has 1,000 unit/mL 2 mL vials, 5,000 unit/mL 2 mL vials, and 10,000 unit/mL 2 mL vials on allocation.
    • Pfizer has 5,000 unit/mL 1 mL Carpuject syringes available in limited supply. The 5,000 unit/mL 1 mL glass vials are on back order and the company estimates a release date of December 2019. The 5,000 unit/mL 10 mL vials (NDC 00409-2723-02) are on back order and the company estimates a release date of December 2019. The 5,000 unit/mL 10 mL glass vials (NDC 00069-0059-01) are on back order and the company estimates a release date of January 2020. The 10,000 unit/mL 0.5 mL Carpuject syringes are available in limited supply. The 1,000 unit/mL 1 mL vials are on back order and the company estimates a release date of November 2019.The 1,000 unit/mL 10 mL vials (NDC 00069-0058-01) are on back order and the company estimates a release date of November 2019.
    • Sagent has heparin 1,000 unit/mL 1 mL, 10 mL, and 30 mL vials on allocation. The 1,000 unit/mL 2 mL vials are on back order with an estimated release date of November 2019. The 5,000 unit/mL 10 mL vials are on allocation. The 10,000 unit/mL 1 mL vials and 20,000 unit/mL 1 mL vials are on allocation. The 10,000 unit/mL 4 mL vials are on back order and the company estimates a release date of November 2019.

Updated

Updated November 13, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 13, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins